FARALLON CAPITAL MANAGEMENT LLC - Q3 2023 holdings

$20 Billion is the total value of FARALLON CAPITAL MANAGEMENT LLC's 159 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 56.0% .

 Value Shares↓ Weighting
HZNP SellHORIZON THERAPEUTICS PUB L$770,127,853
+8.2%
6,656,823
-3.8%
3.86%
+4.4%
TRU SellTRANSUNION$662,855,448
-9.2%
9,233,256
-1.0%
3.32%
-12.4%
IQV SellIQVIA HLDGS INC$544,275,821
-37.4%
2,766,332
-28.5%
2.73%
-39.6%
TMO SellTHERMO FISHER SCIENTIFIC INC$530,228,766
-18.3%
1,047,531
-15.8%
2.66%
-21.1%
GOOG SellALPHABET INCcap stk cl c$469,008,909
+2.0%
3,557,140
-6.4%
2.35%
-1.5%
SPGI SellS&P GLOBAL INC$365,188,927
-16.1%
999,395
-8.0%
1.83%
-19.1%
ADI SellANALOG DEVICES INC$340,024,780
-15.9%
1,942,000
-6.4%
1.70%
-18.8%
CNC SellCENTENE CORP DEL$306,176,766
-4.0%
4,445,075
-6.0%
1.54%
-7.3%
INTU SellINTUIT$284,133,734
-10.3%
556,100
-19.6%
1.42%
-13.4%
YMM SellFULL TRUCK ALLIANCE CO LTDsponsored ads$268,861,085
-5.7%
38,190,495
-16.7%
1.35%
-9.0%
NOW SellSERVICENOW INC$266,931,348
-4.4%
477,550
-3.9%
1.34%
-7.7%
SHW SellSHERWIN WILLIAMS CO$266,984,300
-26.9%
1,046,792
-23.9%
1.34%
-29.4%
BSX SellBOSTON SCIENTIFIC CORP$266,072,770
-2.5%
5,039,257
-0.1%
1.33%
-5.9%
MA SellMASTERCARD INCORPORATEDcl a$240,107,934
-22.2%
606,471
-22.7%
1.20%
-25.0%
BX SellBLACKSTONE INC$238,606,244
-16.1%
2,227,051
-27.2%
1.20%
-19.0%
HWM SellHOWMET AEROSPACE INC$219,577,749
-24.4%
4,747,627
-18.9%
1.10%
-26.9%
AON SellAON PLC$215,820,609
-24.5%
665,661
-19.6%
1.08%
-27.1%
V SellVISA INC$175,131,914
-29.0%
761,410
-26.7%
0.88%
-31.5%
ANTM SellELEVANCE HEALTH INC$166,038,709
-16.1%
381,330
-14.4%
0.83%
-19.0%
SQ SellBLOCK INCcl a$103,406,851
-53.5%
2,336,350
-30.1%
0.52%
-55.2%
SellPDD HOLDINGS INCnote 12/0$75,590,885
-47.3%
76,510,000
-48.1%
0.38%
-49.1%
BABA SellALIBABA GROUP HLDG LTDsponsored ads$74,790,090
-52.0%
862,233
-53.9%
0.38%
-53.6%
PCG SellPG&E CORP$68,095,085
-21.3%
4,221,642
-15.7%
0.34%
-24.1%
HCA SellHCA HEALTHCARE INC$42,898,912
-46.1%
174,400
-33.5%
0.22%
-47.9%
OPCH SellOPTION CARE HEALTH INC$27,885,700
-58.5%
862,000
-58.3%
0.14%
-59.9%
MASI SellMASIMO CORP$19,960,264
-67.0%
227,649
-38.1%
0.10%
-68.2%
AXSM SellAXSOME THERAPEUTICS INC$8,781,888
-55.2%
125,653
-53.9%
0.04%
-56.9%
LU SellLUFAX HOLDING LTD$636,000
-97.8%
600,000
-97.0%
0.00%
-98.0%
SellR1 RCM INC$180,840
-98.2%
12,000
-97.8%
0.00%
-98.1%
COGT SellCOGENT BIOSCIENCES INC$165,750
-98.6%
17,000
-98.3%
0.00%
-98.3%
BPMC SellBLUEPRINT MEDICINES CORP$200,880
-85.8%
4,000
-82.2%
0.00%
-85.7%
EHC SellENCOMPASS HEALTH CORP$201,480
-97.0%
3,000
-97.0%
0.00%
-97.1%
SellEQRX INC*w exp 12/17/202$4,815
-75.3%
120,085
-0.9%
0.00%
NSTDWS ExitNORTHERN STAR INVEST CORP IV*w exp 02/25/202$0-16,666
-100.0%
0.00%
ExitBLUE WHALE ACQUISITION CORP*w exp 07/30/202$0-143,750
-100.0%
0.00%
ExitUTA ACQUISITION CORPORATION*w exp 10/30/202$0-175,000
-100.0%
0.00%
PMGMW ExitPRIVETERRA ACQUISITION CORP*w exp 02/28/202$0-49,995
-100.0%
0.00%
ExitCORSAIR PARTNERING CORP*w exp 07/06/202$0-233,330
-100.0%
0.00%
FMIVW ExitFORUM MERGER IV CORP*w exp 03/15/202$0-250,000
-100.0%
0.00%
ARWR ExitARROWHEAD PHARMACEUTICALS IN$0-5,800
-100.0%
-0.00%
CLVR ExitCLEVER LEAVES HOLDINGS INC$0-1,629,363
-100.0%
-0.00%
ExitBETTER THERAPEUTICS INC$0-330,619
-100.0%
-0.00%
AVRO ExitAVROBIO INC$0-899,700
-100.0%
-0.00%
ICE ExitINTERCONTINENTAL EXCHANGE IN$0-12,786
-100.0%
-0.01%
PRVA ExitPRIVIA HEALTH GROUP INC$0-74,000
-100.0%
-0.01%
ExitATENTO S A$0-2,230,357
-100.0%
-0.01%
ExitALVOTECHordinary shares$0-437,110
-100.0%
-0.02%
ExitUTA ACQUISITION CORPORATION$0-344,100
-100.0%
-0.02%
ExitCARTICA ACQUISITION CORP$0-350,000
-100.0%
-0.02%
ISEE ExitIVERIC BIO INCput$0-100,000
-100.0%
-0.02%
FSRX ExitFINSERV ACQUISITION CORP II$0-400,000
-100.0%
-0.02%
NTLA ExitINTELLIA THERAPEUTICS INC$0-116,000
-100.0%
-0.02%
ExitBLUE WHALE ACQUISITION CORP$0-575,000
-100.0%
-0.03%
ExitCORSAIR PARTNERING CORP$0-700,000
-100.0%
-0.04%
ExitARYA SCIENCES ACQUISITN CORP V$0-745,000
-100.0%
-0.04%
ExitKENSINGTON CAPITAL ACQUISITI V$0-775,200
-100.0%
-0.04%
BRKR ExitBRUKER CORP$0-150,476
-100.0%
-0.06%
LSI ExitLIFE STORAGE INC$0-89,794
-100.0%
-0.06%
ExitSPOTIFY USA INCnote 3/1$0-16,500,000
-100.0%
-0.07%
AEL ExitAMERICAN EQTY INVT LIFE HLD$0-383,000
-100.0%
-0.10%
ExitDRAFTKINGS INC NEWnote 3/1$0-30,000,000
-100.0%
-0.12%
AMAM ExitAMBRX BIOPHARMA INCsponsored ads$0-2,269,000
-100.0%
-0.19%
UTHR ExitUNITED THERAPEUTICS CORP DEL$0-193,267
-100.0%
-0.22%
TSEM ExitTOWER SEMICONDUCTOR LTD$0-1,160,000
-100.0%
-0.23%
RETA ExitREATA PHARMACEUTICALS INCcl a$0-451,700
-100.0%
-0.24%
AJRD ExitAEROJET ROCKETDYNE HLDGS INC$0-959,378
-100.0%
-0.27%
EXAS ExitEXACT SCIENCES CORP$0-602,000
-100.0%
-0.29%
KDNY ExitCHINOOK THERAPEUTICS INC$0-1,523,000
-100.0%
-0.30%
ARGX ExitARGENX SEsponsored adr$0-161,000
-100.0%
-0.33%
ISEE ExitIVERIC BIO INC$0-2,442,299
-100.0%
-0.50%
ExitSEA LTDnote 0.250% 9/1$0-150,000,000
-100.0%
-0.63%
ExitHELLO GROUP INCnote 1.250% 7/0$0-123,449,000
-100.0%
-0.64%
SYNH ExitSYNEOS HEALTH INCcl a$0-3,075,000
-100.0%
-0.67%
BIIB ExitBIOGEN INC$0-604,098
-100.0%
-0.89%
EFX ExitEQUIFAX INC$0-1,058,697
-100.0%
-1.29%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MICROSOFT CORP41Q3 20233.7%
RADIUS HEALTH INC33Q2 20221.7%
GRIFOLS S A33Q4 20210.9%
ALPHABET INC32Q3 20234.2%
SPDR S&P 500 ETF TR31Q3 202325.3%
VISA INC30Q3 20232.9%
WABTEC CORP27Q3 20233.6%
EXELIXIS INC27Q3 20232.8%
ELEVANCE HEALTH INC26Q3 20232.6%
SAVARA INC26Q3 20230.3%

View FARALLON CAPITAL MANAGEMENT LLC's complete holdings history.

Latest significant ownerships (13-D/G)
FARALLON CAPITAL MANAGEMENT LLC Q3 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Atento S.A.March 15, 20232,230,35715.4%
Metals Acquisition CorpFebruary 07, 20232,489,7009.4%
Inflection Point Acquisition Corp.February 06, 20231,900,0005.8%
AMYRIS, INC.February 24, 20221,068,9040.3%
Swiftmerge Acquisition Corp.February 14, 2022291,0601.3%
Caribou Biosciences, Inc.February 11, 20222,428,1504.0%
ENANTA PHARMACEUTICALS INCFebruary 11, 2022287,0001.4%
Protagonist Therapeutics, IncFebruary 11, 2022387,0510.8%
Solid Power, Inc.February 11, 2022? ?
Better Therapeutics, Inc.February 09, 2022124,0650.5%

View FARALLON CAPITAL MANAGEMENT LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR/A2024-02-14
13F-HR2024-02-14
13F-HR/A2024-02-12
SC 13G/A2024-02-01
SC 13G/A2024-01-23

View FARALLON CAPITAL MANAGEMENT LLC's complete filings history.

Compare quarters

Export FARALLON CAPITAL MANAGEMENT LLC's holdings